Please ensure Javascript is enabled for purposes of website accessibility

Why Female Health Is Poised to Outperform

By Brian D. Pacampara, CFA - Apr 2, 2013 at 6:11PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Market-trouncing returns could be written in this 5-Star.

Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, female condom maker Female Health (VERU 5.53%) has earned a coveted five-star ranking.

With that in mind, let's take a closer look at Female Health and see what CAPS investors are saying about the stock right now.

Female Health facts

 

 

Headquarters (founded)

Chicago, Ill. (1896)

Market Cap

$225.6 million

Industry

Personal products

Trailing-12-Month Revenue

$36.3 million

Management

Chairman/CEO O.B. Parrish

CFO Michele Greco

Return on Equity (average, past 3 years)

60.6%

Cash/Debt

$4.3 million/$0

Dividend Yield

3.3%

Competitors

Church & Dwight 

Sources: S&P Capital IQ and Motley Fool CAPS.

On CAPS, 97% of the 333 members who have rated Female Health believe the stock will outperform the S&P 500 going forward.

Just last week, one of those Fools, All-Star BKITU, succinctly summed up the Female Health bull case for our community: "Decent financials, consumable product, lots of growth potential not only in industrializing countries, but in already-industrialized countries. That's a rare treat these days."

 Want to see how well (or not so well) the stocks in this series are performing? Follow the TrackPoisedTo CAPS account.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

The Female Health Company Stock Quote
The Female Health Company
VERU
$14.12 (5.53%) $0.74

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
330%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/24/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.